SEC Form 4 · accession 0001209191-19-008088
PROTEOSTASIS THERAPEUTICS, INC. · PTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Emmanuel Dulac
Director
Period of report
Feb 5, 2019
Accepted (ET)
Feb 7, 2019 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001445283
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.11 | Feb 5, 2019 | A | 30,600 | A | — | Feb 5, 2029 | Common Stock | 30,600 | 30,600 | D |
Explanation of responses
- F1These securities shall vest and become exercisable in equal quarterly installments starting on May 5, 2019 until the option is fully vested and exercisable on February 5, 2020, subject to continued service.